Neopterin Profile to Evaluate the Effectiveness of Treatment in Aggressive Periodontitis

Verfasser / Beitragende:
[Aysen Bodur, Terken Baydar, Nurdan Ozmeric, Ayse Basak Engin, Ahu Uraz, Kaya Eren, Gonul Sahin]
Ort, Verlag, Jahr:
2003
Enthalten in:
Pteridines, 14/3(2003-08), 77-81
Format:
Artikel (online)
ID: 378852906
LEADER caa a22 4500
001 378852906
003 CHVBK
005 20180305123328.0
007 cr unu---uuuuu
008 161128e200308 xx s 000 0 eng
024 7 0 |a 10.1515/pteridines.2003.14.3.77  |2 doi 
035 |a (NATIONALLICENCE)gruyter-10.1515/pteridines.2003.14.3.77 
245 0 0 |a Neopterin Profile to Evaluate the Effectiveness of Treatment in Aggressive Periodontitis  |h [Elektronische Daten]  |c [Aysen Bodur, Terken Baydar, Nurdan Ozmeric, Ayse Basak Engin, Ahu Uraz, Kaya Eren, Gonul Sahin] 
520 3 |a Periodontal disease results from the interaction of the host defence mechanisms with the microbial dental plaque. Analysis of gingival crevicular Huid (GCF) provides a non-invasive means of evaluating the role of the host response in periodontal disease. Based on our previous study, demonstrating increased levels of neopterin in GCF and saliva from patients with aggressive periodontitis (AgP), the aim of this study was to evaluate the effect of periodontal treatment on the levels of neopterin in GCF, saliva and urine of patients with AgP. Pre-treatment values of neopterin in GCF were 4.04 ± 0.86 nmol/ml for the AgP group (n=8) and 2.68 ± 0.90 nmol/ml fyr the control group (n=8; difference not significant). After periodontal treatment, the level of ncoptei in was found 2.38 ± 0.72 nmol/ml in the patient group which did not differ f r om pre-treatment levels. The salivary neopterin concentration was higher in both AgP groups (14.14 ± 2.85 nmol/1 and 8.02 ± 3.12 nmol/1, before and after periodontal treatment) than in controls (2.58 ± 0.3 nmol/1; both p<0.05). No significant difference in salivary neopterin level was observed in patients before and after periodontal treatment. Concentrations of urine neopterin in patients before treatment were 188.5 ± 30.98 μηιοί neopterin/mol creatinine and 168.1 + 20.21 μηιοί in controls (difference not significant). Following periodontal treatment, the urinary neopterin levels (310.1 ± 39.82 μηιοί neopterin/mol creatinine) were higher when compared to the baseline levels and to controls (p<0.05). Our results suggest that neopterin in saliva and GCF might be associated with the periodontal diseases process. 
540 |a © 2013 by Walter de Gruyter GmbH & Co. 
690 7 |a neopterin  |2 nationallicence 
690 7 |a gingival crevicular fluid  |2 nationallicence 
690 7 |a saliva  |2 nationallicence 
690 7 |a urine  |2 nationallicence 
690 7 |a aggressive periodontitis  |2 nationallicence 
700 1 |a Bodur  |D Aysen  |u Department of Peri odontology, Faculty of Dentistry, Gazi University, 06510 Ankara, Turkey  |4 aut 
700 1 |a Baydar  |D Terken  |u Department of Toxicology, Faculty of Pharmacy, Hacettepe University, 06100 Ankara, Turkey  |4 aut 
700 1 |a Ozmeric  |D Nurdan  |u Department of Peri odontology, Faculty of Dentistry, Gazi University, 06510 Ankara, Turkey  |4 aut 
700 1 |a Engin  |D Ayse Basak  |u Department of Toxicology, Faculty of Pharmacy, Hacettepe University, 06100 Ankara, Turkey  |4 aut 
700 1 |a Uraz  |D Ahu  |u Department of Peri odontology, Faculty of Dentistry, Gazi University, 06510 Ankara, Turkey  |4 aut 
700 1 |a Eren  |D Kaya  |u Department of Peri odontology, Faculty of Dentistry, Gazi University, 06510 Ankara, Turkey  |4 aut 
700 1 |a Sahin  |D Gonul  |u Department of Toxicology, Faculty of Pharmacy, Hacettepe University, 06100 Ankara, Turkey  |4 aut 
773 0 |t Pteridines  |d De Gruyter  |g 14/3(2003-08), 77-81  |x 0933-4807  |q 14:3<77  |1 2003  |2 14  |o pteridines 
856 4 0 |u https://doi.org/10.1515/pteridines.2003.14.3.77  |q text/html  |z Onlinezugriff via DOI 
908 |D 1  |a research article  |2 jats 
950 |B NATIONALLICENCE  |P 856  |E 40  |u https://doi.org/10.1515/pteridines.2003.14.3.77  |q text/html  |z Onlinezugriff via DOI 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Bodur  |D Aysen  |u Department of Peri odontology, Faculty of Dentistry, Gazi University, 06510 Ankara, Turkey  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Baydar  |D Terken  |u Department of Toxicology, Faculty of Pharmacy, Hacettepe University, 06100 Ankara, Turkey  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Ozmeric  |D Nurdan  |u Department of Peri odontology, Faculty of Dentistry, Gazi University, 06510 Ankara, Turkey  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Engin  |D Ayse Basak  |u Department of Toxicology, Faculty of Pharmacy, Hacettepe University, 06100 Ankara, Turkey  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Uraz  |D Ahu  |u Department of Peri odontology, Faculty of Dentistry, Gazi University, 06510 Ankara, Turkey  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Eren  |D Kaya  |u Department of Peri odontology, Faculty of Dentistry, Gazi University, 06510 Ankara, Turkey  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Sahin  |D Gonul  |u Department of Toxicology, Faculty of Pharmacy, Hacettepe University, 06100 Ankara, Turkey  |4 aut 
950 |B NATIONALLICENCE  |P 773  |E 0-  |t Pteridines  |d De Gruyter  |g 14/3(2003-08), 77-81  |x 0933-4807  |q 14:3<77  |1 2003  |2 14  |o pteridines 
900 7 |b CC0  |u http://creativecommons.org/publicdomain/zero/1.0  |2 nationallicence 
898 |a BK010053  |b XK010053  |c XK010000 
949 |B NATIONALLICENCE  |F NATIONALLICENCE  |b NL-gruyter